Atai Beckley N.V. (DE:B72)

XETRA:B72

B72

Atai Beckley N.V.

RESEARCH TOOLSreports

Want to see DE:B72 full AI Analyst Report?

Atai Beckley N.V. (B72) Stock Forecast & Price Target

12 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

B72 Analyst Ratings

Strong Buy

11 Buy

0 Hold

0 Sell

Based on 11 analysts giving stock ratings to

Atai

Beckley N.V.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

B72 Stock 12 Month Forecast

Average Price Target

€12.59

▲(245.75% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Atai Beckley N.V. in the last 3 months. The average price target is €12.59 with a high forecast of €21.26 and a low forecast of €8.50. The average price target represents a 245.75% change from the last price of €3.64.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","11":"€11","22":"€22","5.5":"€5.5","16.5":"€16.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":21.2587565,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€21.26</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.585183848000002,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€12.59</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.503502600000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€8.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,5.5,11,16.5,22],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.48,4.8475966538461535,6.215193307692308,7.582789961538461,8.950386615384616,10.31798326923077,11.685579923076924,13.053176576923079,14.420773230769232,15.788369884615385,17.155966538461538,18.523563192307694,19.891159846153847,{"y":21.2587565,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.48,4.180398757538462,4.880797515076923,5.581196272615385,6.281595030153847,6.981993787692308,7.682392545230769,8.382791302769231,9.083190060307693,9.783588817846155,10.483987575384615,11.184386332923077,11.88478509046154,{"y":12.585183848000002,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.48,3.866423276923077,4.252846553846154,4.639269830769231,5.025693107692308,5.412116384615385,5.798539661538461,6.184962938461538,6.571386215384615,6.9578094923076925,7.34423276923077,7.730656046153847,8.117079323076924,{"y":8.503502600000001,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.325,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.98,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.229,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.434,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.998,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.448,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.016,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.231,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.426,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.426,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.9,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.16,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.48,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€21.26

Average Price Target€12.59

Lowest Price Target€8.50

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Patrick Trucchio

H.C. Wainwright

€21.26

Buy

484.03%

Upside

Reiterated

04/28/26

Atai Beckley N.V. (ATAI) Receives a Buy from H.C. Wainwright

Ritu Baral

TD Cowen

―

Buy

―

Reiterated

04/23/26

Analysts Offer Insights on Healthcare Companies: NervGen Pharma (NASDAQ: NGEN), Atai Beckley N.V. (NASDAQ: ATAI) and Journey Medical Corp (NASDAQ: DERM)

Ami Fadia

Needham

€11.9

Buy

227.06%

Upside

Reiterated

04/22/26

Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (NASDAQ: ATAI) and Greenwich LifeSciences (NASDAQ: GLSI)

Justin Walsh

JonesTrading

€13.61

Buy

273.78%

Upside

Reiterated

04/22/26

Reiterated Buy on Atai Beckley as Robust EMP-01 Phase IIa Data and Solid Cash Position Support $16 Price Target

Sumant Kulkarni

Canaccord Genuity

€11.9→€12.76

Buy

250.42%

Upside

Reiterated

04/20/26

Analysts Are Bullish on Top Healthcare Stocks: Merit Medical Systems (MMSI), Atai Beckley N.V. (ATAI)

Harry Gillis

Berenberg Bank

€11.05→€11.9

Buy

227.06%

Upside

Reiterated

04/20/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Eddie Hickman

Guggenheim

€9.35→€13.61

Buy

273.78%

Upside

Reiterated

04/16/26

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY) and Atai Beckley N.V. (NASDAQ: ATAI)

Jay Olson

Oppenheimer

€11.9→€13.61

Buy

273.78%

Upside

Assigned

04/05/26

Analysts Are Bullish on These Healthcare Stocks: Atai Beckley N.V. (ATAI), MapLight Therapeutics, Inc. (MPLT)

David Hoang

Deutsche Bank

€10.2

Buy

180.34%

Upside

Initiated

03/26/26

AtaiBeckley initiated with a Buy at Deutsche BankAtaiBeckley initiated with a Buy at Deutsche Bank

Michael Okunewitch

Maxim Group

€8.5

Buy

133.61%

Upside

Assigned

03/17/26

AtaiBeckley: Advancing BPL-003 Into Pivotal Phase 3 With Strategic Optionality and Strong Cash Runway Supporting a Buy Rating

Andrew Tsai

Jefferies

€8.5

Buy

133.61%

Upside

Reiterated

03/09/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Nathan Weinstein

Aegis Capital

€6.8

Buy

86.89%

Upside

Reiterated

07/02/25

Aegis Capital Remains a Buy on ATAI Life Sciences (ATAI)

Elemer Piros

Lucid Capital

€10.2

Buy

180.34%

Upside

Initiated

06/06/25

Atai Life Sciences initiated with a Buy at Lucid CapitalAtai Life Sciences initiated with a Buy at Lucid Capital

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Patrick Trucchio

H.C. Wainwright

€21.26

Buy

484.03%

Upside

Reiterated

04/28/26

Atai Beckley N.V. (ATAI) Receives a Buy from H.C. Wainwright

Ritu Baral

TD Cowen

―

Buy

―

Reiterated

04/23/26

Analysts Offer Insights on Healthcare Companies: NervGen Pharma (NASDAQ: NGEN), Atai Beckley N.V. (NASDAQ: ATAI) and Journey Medical Corp (NASDAQ: DERM)

Ami Fadia

Needham

€11.9

Buy

227.06%

Upside

Reiterated

04/22/26

Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (NASDAQ: ATAI) and Greenwich LifeSciences (NASDAQ: GLSI)

Justin Walsh

JonesTrading

€13.61

Buy

273.78%

Upside

Reiterated

04/22/26

Reiterated Buy on Atai Beckley as Robust EMP-01 Phase IIa Data and Solid Cash Position Support $16 Price Target

Sumant Kulkarni

Canaccord Genuity

€11.9→€12.76

Buy

250.42%

Upside

Reiterated

04/20/26

Analysts Are Bullish on Top Healthcare Stocks: Merit Medical Systems (MMSI), Atai Beckley N.V. (ATAI)

Harry Gillis

Berenberg Bank

€11.05→€11.9

Buy

227.06%

Upside

Reiterated

04/20/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Eddie Hickman

Guggenheim

€9.35→€13.61

Buy

273.78%

Upside

Reiterated

04/16/26

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY) and Atai Beckley N.V. (NASDAQ: ATAI)

Jay Olson

Oppenheimer

€11.9→€13.61

Buy

273.78%

Upside

Assigned

04/05/26

Analysts Are Bullish on These Healthcare Stocks: Atai Beckley N.V. (ATAI), MapLight Therapeutics, Inc. (MPLT)

David Hoang

Deutsche Bank

€10.2

Buy

180.34%

Upside

Initiated

03/26/26

AtaiBeckley initiated with a Buy at Deutsche BankAtaiBeckley initiated with a Buy at Deutsche Bank

Michael Okunewitch

Maxim Group

€8.5

Buy

133.61%

Upside

Assigned

03/17/26

AtaiBeckley: Advancing BPL-003 Into Pivotal Phase 3 With Strategic Optionality and Strong Cash Runway Supporting a Buy Rating

Andrew Tsai

Jefferies

€8.5

Buy

133.61%

Upside

Reiterated

03/09/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Nathan Weinstein

Aegis Capital

€6.8

Buy

86.89%

Upside

Reiterated

07/02/25

Aegis Capital Remains a Buy on ATAI Life Sciences (ATAI)

Elemer Piros

Lucid Capital

€10.2

Buy

180.34%

Upside

Initiated

06/06/25

Atai Life Sciences initiated with a Buy at Lucid CapitalAtai Life Sciences initiated with a Buy at Lucid Capital

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Atai Beckley N.V.

3 Months

xxx

Success Rate

10/13 ratings generated profit

Average Return

+28.18%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +28.18% per trade.

1 Year

Michael OkunewitchMaxim Group

Success Rate

10/13 ratings generated profit

Average Return

+54.65%

Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 76.92% of your transactions generating a profit, with an average return of +54.65% per trade.

2 Years

xxx

Success Rate

14/16 ratings generated profit

Average Return

+117.95%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +117.95% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

B72 Analyst Recommendation Trends

Rating

Jan 26

Feb 26

Mar 26

Apr 26

May 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, B72 has received 23 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. B72 average Analyst price target in the past 3 months is 12.59.

Each month's total comprises the sum of three months' worth of ratings.

B72 Financial Forecast

B72 Earnings Forecast

Currently, no earnings data available.

B72 Sales Forecast

Currently, no sales data available.

B72 Stock Forecast FAQ

What is DE:B72’s average 12-month price target, according to analysts?

Based on analyst ratings, Atai Beckley N.V.’s 12-month average price target is 12.59.

What is DE:B72’s upside potential, based on the analysts’ average price target?

Atai Beckley N.V. has 245.75% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Atai Beckley N.V. a Buy, Sell or Hold?

Atai Beckley N.V. has a consensus rating of Strong Buy, which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.

What is Atai Beckley N.V.’s share price target?

The average share price target for Atai Beckley N.V. is 12.59. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €21.26 ,and the lowest forecast is €8.50. The average share price target represents 245.75% Increase from the current price of €3.64.

What do analysts say about Atai Beckley N.V.?

Atai Beckley N.V.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of Atai Beckley N.V.?

To buy shares of DE:B72, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Atai Beckley N.V. (B72) Stock Forecast & Price Target

B72 Analyst Ratings

B72 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Atai Beckley N.V.

B72 Analyst Recommendation Trends

B72 Financial Forecast

B72 Earnings Forecast

B72 Sales Forecast

B72 Stock Forecast FAQ

Detailed List of Analyst Forecasts